NHTSA Releases Draft Test Procedures for Advanced Driver Assistance Systems

On November 21, 2019, the National Highway Traffic Safety Administration (“NHTSA”) released nine draft test procedures intended to help evaluate certain types of Advanced Driver Assistance Systems (“ADAS”). NHTSA is seeking public comment regarding the adequacy of these test procedures … Continue reading

Posted in Uncategorized

Share this Article:

Service Contracts Are Not Express Warranties Under the Song-Beverly Consumer Warranty Act

In Gavaldon v. DaimlerChrysler Corp. (2004) 32 Cal. 4th 1246, the California Supreme Court found that service contracts are not express warranties under the Song-Beverly Consumer Warranty Act and the Act did not otherwise authorize replacement or restitution as a … Continue reading

Posted in Uncategorized

Share this Article:

California Supreme Court Clarifies Whether Counsel is Bound by Confidentiality Provisions in Settlement Agreements

In Monster Energy Co. v. Schechter, 7 Cal.5th 781, 792 (2019) the California Supreme Court was tasked with determining “whether counsel’s signature approving a agreement as to form and content for his clients’ signature precludes, as a matter of law, … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , ,

Share this Article:

Collateral Source Rule Not Violated by References to Medical Insurance, Medicare and Social Security

Stokes v. Muschinske, No. B280116, 2019 WL 1513208 (Cal. Ct. App. Mar. 14, 2019) (awaiting official publication) begs the question, does reference to a plaintiff’s membership in a health care plan, like Kaiser Permanente, or Medicare eligibility violate the collateral … Continue reading

Posted in Uncategorized

Share this Article:

Product Liability Litigation Group Ranked in 2019 “Best Law Firms”

Snell & Wilmer’s Product Liability Litigation Group achieved high rankings in 2019’s “Best Law Firms” by U.S. News Media Group and Best Lawyers®. We were ranked as a metropolitan area Tier 1 firm in Phoenix, Orange County, Colorado and Utah … Continue reading

Posted in litigation, products, Trials, Uncategorized

Share this Article:

Location, Location, Location – A Brief Overview of Personal Jurisdiction, Forum Selection Clauses, and Why They Matter

Where a case is heard can make a critical difference to a company that is being sued. Will the company have the “home court” advantage and a jury that will know the company’s business, that the company employs people in … Continue reading

Posted in litigation, Uncategorized

Share this Article:

Product Liability Litigation Group Ranked in 2016 “Best Law Firms”

Snell & Wilmer’s Product Liability Litigation Group achieved high rankings in “Best Law Firms” by U.S. News Media Group and Best Lawyers®. We were ranked as a metropolitan area Tier 1 firm in Phoenix, Colorado and Utah for product liability … Continue reading

Posted in litigation, products, Uncategorized

Share this Article:

What’s The “Internet of Things” and What Are Its Legal Challenges?

The “Internet of Things” is the universe of smart devices that talk to the internet or to one another. The devices have unique identifiers and the ability to automatically transfer data over a network on their own, without human interaction. Some examples … Continue reading

Posted in Uncategorized

Share this Article:

Summary of FDA’s Final Guidance on Dear Health Care Provider Letters

At the beginning of this year, the Food and Drug Administration (FDA) issued its final guidance on the content and format of Dear Health Care Provider (DHCP) letters. DHCP letters are correspondence, often in the form of a mass mailing … Continue reading

Posted in consumer products, FDA, guidance, medical, pharmaceutical, Uncategorized

Share this Article:

Drug and Device Manufacturers Beware: Comments Could Result in FDA Troubles

After appearing on CNBC television show Fast Money, the CEO of Aegerion Pharmaceuticals received a warning letter from the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion.  The agency asserted that comments made on the show … Continue reading

Posted in FDA, pharmaceutical, Uncategorized

Share this Article: